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Chronic kidney disease (CKD) is a large and grow-
ing problem among aging populations. Patients over 
65 years of age represent the most rapidly growing 
segment of the end -stage renal disease (ESRD) 
population in wealthier countries1,2, as well as show-
ing a high prevalence of earlier stages of CKD, with 
relative prevalence equally striking for populations 
in the USA, Canada and Europe1,3 -5. One of the 
major challenges to clinicians caring for older CKD 
patients expected to progress to ESRD lies in evalu-
ating the overall benefit of offering renal replace-
ment therapy to them. Although survival may have 
improved over time for older patients initiating 
dialysis6, dialysis may be associated with only a 
limited survival benefit, when comparing to con-
servative management, as demonstrated by several 
studies7,8, with an overall decline in functional 
status9,more hospitalization10, and a poor quality 
of life. So, among elderly patients with a high bur-
den of comorbidity, conservative management may, 
therefore, be a therapeutic option, as dialysis is 
unlikely to prolong or improve quality of life. To 
offer that option is extremely important to incor-
porate conservative care pathways into clinical 
practice, and prioritizes an individualized patient 
centred model of care.
Brown et al.11 presented data supporting conserva-
tive care pathways in an excellent prospective obser-
vational study, demonstrated that symptoms can be 
effectively controlled and that patients experience 
similar quality of life with or without dialysis. In their 
programme, patients are seen by both the nephrolo-
gist and a palliative care team11, with specifically but 
convertible tasks. The palliative care team members 
manage physical symptoms and psychological issues 
and help with advance care planning, whereas the 
nephrology team manages CKD related complications, 
like anaemia, fluid balance and try to preserve resid-
ual renal function.
In this renal supportive care programme, elderly 
patients with advanced CKD who choose not to do 
dialysis survived a median of 16 months with a 53% 
1 -year survival from the time of referral to the pro-
gramme. Although these patients had a lower survival 
than younger patients attending the pre -dialysis clinic 
with a planned future dialysis, there was no signiﬁcant 
difference in their adjusted survival compared with 
a third group of patients who commenced dialysis, 
during the same period, without attending the pre-
-dialysis clinic. Moreover, above two thirds of patients 
in the renal supportive care programme group 
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achieved improvement in their symptom burden by 
6 and 12 months11.
Conservative management programmes are 
developing around the world to help care for 
patients who choose no dialysis therapy. Although 
the majority of these programmes are still in the 
beginning are projected to increase over time and 
may care for an estimated 10% to 20% of the ESRD 
population12.
It is essential to increase the training and educa-
tion of nephrologists in the care of geriatric patients13, 
namely in the conservative management of ESRD. 
They need to be confident in recognizing and man-
aging ESRD related symptoms, to be aware when 
to refer to palliative care, and they should be com-
fortable with end -of -life discussions and providing 
prognostic information to patients, families and 
caregivers14.
For evaluating renal replacement therapy ben-
efits and risks and informing patients and their 
families about ESRD treatment options, there is 
recently an interest in developing predictive mor-
tality models for incident and prevalent dialysis 
patients15 -17. Applying predictive mortality models 
can be useful, although these models currently 
fail to address the key question of clinical utility18, 
and maybe they are best used to offer information 
and initiate reflections integrated in a shared 
decision -making process.
Although these prognostic tools may also help to 
identify patients at high risk of early death with 
whom conservative management may be a better 
option, not all patients starting dialysis with a high 
score, have a poor prognostic. And it is important 
to note that a high symptom burden exists in both 
those patients opting for dialysis and those patients 
opting for a conservative therapy, as shown by Brown 
et al.11.
Symptoms, such as chronic pain, fatigue, difficulty 
sleeping, itchy skin, restless legs, cognitive impair-
ment, and depression are very common in ESRD 
patients, as evidenced by several studies, often simi-
lar to the burden carried by cancer patients19,20. 
Brown et al.11 demonstrated that palliative care teams 
could reduce the symptom burden in both, dialysis 
and no dialysis groups.
So, this study draws our attention to the impor-
tance to implement an effective collaborative pro-
gramme with palliative care planning, also for dialysis 
patients rather than to limit symptom management 
to those who choose not to do dialysis.
In the management of patients with complex mor-
bidity, as is the case for many ESRD patients, we 
must incorporate palliative and other supportive 
interventions to address symptom burden, rehabilita-
tion, and end -of -life care, towards a patient -centred 
vision of care21,22.
The nephrology community needs to overcome 
barriers and move to the implementation and effec-
tiveness of advance care planning programmes, in 
order to provide the best care for our patients and 
their families.
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